February 20, 2020: Rachael Guenter presents her work “Establishment of a Notch1-knockout Neuroendocrine Cancer Cell Line Using CRISPR/Cas9 Technology” at the O’Neal Comprehensive Cancer Center Trainee Seminar Series.
O’Neal CCC Seminar
February 20, 2020: Rachael Guenter presents her work “Establishment of a Notch1-knockout Neuroendocrine Cancer Cell Line Using CRISPR/Cas9 Technology” at the O’Neal Comprehensive Cancer Center Trainee Seminar Series.
